News Search Results
Sep 05, 2025, 10:30 ET Mabwell Secures Pakistan's First Denosumab Injection Approval
Pakistan's leading pharmaceutical companies, with eight state-of-the-art manufacturing facilities, including a dedicated biotechnology plant. With operations in over 20 countries and rapid expansion across multiple global regions, Searle is committed to delivering innovative treatments
More news about: Mabwell
Sep 05, 2025, 10:15 ET Hearing Aids Market is Expected to Reach US$45.68 Billion by 2031; Record a CAGR of 6.9% during the forecast period | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Logo:
More news about: The Insight Partners
Sep 05, 2025, 10:01 ET With 7.9% CAGR; Functional Safety Market Experiences Growth Owing to Increased Automation Across Industries by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 05, 2025, 08:49 ET ZINZINO AB (PUBL.): LETTER OF INTENT TO ACQUIRE TRUVY FOR INCREASED DISTRIBUTION POWER IN NORTH AMERICA, LATIN AMERICA, AND SOUTH KOREA
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales. Truvy is a global direct sales company in the health segment,
More news about: Zinzino
Sep 05, 2025, 08:37 ET Refrigeration Cooler Market Size is Projected To Reach US$7.48 Billion By 2031 at 6.4% GAGR |The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 05, 2025, 08:30 ET How Digital Cleaning Validation Improves OEE and Reduces Costs, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 05, 2025, 08:30 ET Clinical Research in LATAM: From a Standalone Site to a Regional Network, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 05, 2025, 08:30 ET Advanced Therapy Safety Management: Proactive Strategies for Real-World Risk Detection, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 05, 2025, 08:00 ET Hengrui Pharma and Braveheart Bio Enter Exclusive License Agreement for Cardiac Myosin Inhibitor HRS-1893
inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential. Braveheart Bio is a newly launched, U.S.-based biotechnology company focused on cardiovascular disease with a consortium of lead investors that includes Forbion, OrbiMed, and others. Under the terms
More news about: Jiangsu Hengrui Pharmaceuticals Co., Ltd
Sep 05, 2025, 07:05 ET REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II
which has been shown to correlate with neurocognitive manifestations of the disorder. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Sep 05, 2025, 04:09 ET Immunofoco Earns Spot on Forbes Asia 100 to Watch 2025 List for Leading New Wave in Solid Tumor Cell Therapy
SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company, focused on developing novel cell therapies for solid tumors, has been selected for the prestigious "Forbes Asia 100 to Watch 2025" list.
More news about: Immunofoco
Sep 05, 2025, 01:00 ET Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Sep 05, 2025, 01:00 ET Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Sep 04, 2025, 17:18 ET CAGE Bio Reports Strong Results from its Phase 2b Atopic Dermatitis Trial
SAN CARLOS, Calif., Sept. 4, 2025 /PRNewswire/ -- CAGE Bio, a biotechnology company advancing ionic liquid–based therapies for immune-mediated skin diseases, today announced positive topline results from its double-blinded,
More news about: CAGE Bio Inc.
Sep 04, 2025, 16:01 ET AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Sep 04, 2025, 15:46 ET BiotechBeauty® Launches at Credo Beauty with Nationwide Pop-Up Series
® is a skin-improving makeup brand merging biotechnology with high-performance color. Developed through years of research, its formulas use bioengineered ingredients that support the skin's microbiome
More news about: BiotechBeauty
Sep 04, 2025, 13:24 ET EverHive Expands Into APAC, Establishing Singapore Hub to Support Regional Growth
global footprint, with programs now spanning more than 40 countries across North America, EMEA, and APAC. From biotechnology and financial services to technology and gaming, EverHive continues to deliver measurable results for industries that demand agility and innovation.
More news about: EverHive Corp
Sep 04, 2025, 11:56 ET Probiotics Market Hits USD 108 Billion in 2031, Driven by Preventive Healthcare Trends | DataM Intelligence
between food companies and biotech firms to develop advanced probiotic strains. For example, several U.S. based dairy producers have partnered with biotechnology startups in the last three months to expand their probiotic-rich product lines. The supplements sector is also witnessing heightened activity, with
More news about: DataM Intelligence 4 Market Research LLP
Sep 04, 2025, 11:42 ET MSC-Specific Cell Culture Medium Market to Reach USD 4.1 Billion by 2035, with CAGR 11.6% Driven by Regenerative Medicine and Stem Cell Therapy Growth
and xeno-free MSC-specific media dominated in 2024, ensuring higher safety and compliance for therapeutic use.By Application: Pharmaceutical & Biotechnology Companies accounted for the largest shareRegional Leadership: North America led in 2024 with market share
More news about: Vantage Market Research
Sep 04, 2025, 10:01 ET Telecom Cloud Market is Projected to Reach US$ 91.92 Billion By 2031; it is Expected To Register a CAGR of 22.4% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 04, 2025, 08:49 ET NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced it has entered into a definitive agreement with a single
More news about: NeuroSense
Sep 04, 2025, 08:42 ET BrainSpec and University of Minnesota Collaborate to Advance Automation in MR Spectroscopy with AutoVOI
University of Minnesota's Center for Magnetic Resonance Research Center for Magnetic Resonance Research (CMRR), funded as a Biotechnology Research Center (BTRC) by the National Center for Research Resources (NCRR) until 2012 and by the National Institute of Biomedical Imaging and Bioengineering
More news about: BrainSpec
Sep 04, 2025, 08:30 ET Advancing Gene Therapy Development with Monoclonal HEK293 Cell Isolation for Regulatory Compliance, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 04, 2025, 08:30 ET Overcoming Bioanalytical Challenges in Anti-Drug Antibody Detection for ADCs, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 04, 2025, 08:15 ET Healthcare Industry Veteran Scott Rairigh Joins Psilera to Lead Corporate Development
Fla., Sept. 4, 2025 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a biotechnology company developing groundbreaking therapies for complex neurological disorders, has appointed Scott W. Rairigh as
More news about: Psilera, Inc.